Viewing Study NCT01944735


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2025-12-30 @ 4:40 PM
Study NCT ID: NCT01944735
Status: COMPLETED
Last Update Posted: 2015-03-06
First Post: 2013-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients
Sponsor: Celtaxsys, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module